The investor call was really important - reinforced a lot of what we already know but additionally put the market at ease.
You are also correct in saying: "If proven the technology could be groundbreaking" - the funny thing is it is pretty much proven with multiple in clinic research papers already noting neurofeedback's effectiveness. All NTI is doing is it is taking it out of the clinic and putting the practive into the home where it is best suited to the client.
Most importantly is there is no other 'in home' product on the market that does what the Mente autism device by NTI does. Most surprisingly is that NTI only has a $18 market Cap. Totally crazy considering NTI's preliminary results, prior research proving neurofeedback works (in clinic) and that autism effects one in 68 children.
That is one massive untapped market!
NTI Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
(20min delay)
